173334-58-2
Chemical Structure
Aliskiren hemifumarate
Synonym(s): CGP 60536 hemifumarate; CGP60536B hemifumarate; SPP 100 hemifumarate
- CAS No.: 173334-58-2
- Formula:C64H110N6O16
- Molecular Weight:1219.59
IUPAC Name: (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methylnonanamide hemifumarate
InChIKey: KLRSDBSKUSSCGU-KRQUFFFQSA-N
SMILES: O=C(O)/C=C/C(O)=O.O=C(NCC(C)(C(N)=O)C)[C@@H](C[C@@H]([C@H](C[C@@H](C(C)C)CC1=CC=C(OC)C(OCCCOC)=C1)N)O)C(C)C.O=C(NCC(C)(C(N)=O)C)[C@H](C(C)C)C[C@H](O)[C@@H](N)C[C@@H](C(C)C)CC2=CC=C(OC)C(OCCCOC)=C2
Biological Activity: Aliskiren (CGP 60536; CGP60536B; SPP 100) hemifumarate is an orally active and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren hemifumarate can be used for the research of hypertension, cardiovascular diseases and cancer cachexia[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Aliskiren hemifumarate | 99.62% | Aliskiren (CGP 60536; CGP60536B; SPP 100) hemifumarate is an orally active and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren hemifumarate can be used for the research of hypertension, cardiovascular diseases and cancer cachexia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Aliskiren hemifumarate (Standard) | ≥98% | Aliskiren (hemifumarate) (Standard) is the analytical standard of Aliskiren (hemifumarate). This product is intended for research and analytical applications. Aliskiren (CGP 60536; CGP60536B; SPP 100) hemifumarate is an orally active and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren hemifumarate can be used for the research of hypertension, cardiovascular diseases and cancer cachexia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Aliskiren-d6 hemifumarate | 99.33% | Aliskiren-d6 (hemifumarate) is a deuterium labeled Aliskiren hemifumarate. Aliskiren hemifumarate is a direct and orally active renin inhibitor with an IC50 of 1.5 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.69
HY-12176BAliskiren fumarate -
Similarity Score 0.63
HY-12176AAliskiren hydrochloride -
Similarity Score 0.63
HY-12176Aliskiren -
Similarity Score 0.57
HY-12176ASAliskiren-d6 hydrochloride -
Similarity Score 0.46
HY-P5489IGRP(206-214) -
Similarity Score 0.46
HY-182264Masoprocol tetrapivalate -
Similarity Score 0.46
HY-P1059Pep2-AVKI -
Similarity Score 0.45
HY-P1056pep2-SVKI -
Similarity Score 0.45
HY-P1054pep2-EVKI -
Explore the MedChemAI to find more analogs
References
- [1]. Yuji Nakamura, et al. Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor. ACS Med. Chem. Lett., 2012, 3 (9), pp 754-758
- [2]. Ferri N, et al. Aliskiren inhibits prorenin-induced human aortic smooth muscle cell migration. J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):284-91. [Content Brief]
- [3]. Wood JM, et al. Structure-based design of aliskiren, a novel orally effective renin inhibitor.Biochem Biophys Res Commun, 2003, 308(4), 698-705. [Content Brief]
